CN104254338B - 用于治疗尿失禁和遗尿症的药物组合物 - Google Patents

用于治疗尿失禁和遗尿症的药物组合物 Download PDF

Info

Publication number
CN104254338B
CN104254338B CN201380009507.7A CN201380009507A CN104254338B CN 104254338 B CN104254338 B CN 104254338B CN 201380009507 A CN201380009507 A CN 201380009507A CN 104254338 B CN104254338 B CN 104254338B
Authority
CN
China
Prior art keywords
composition
urinary incontinence
enuresis
treatment
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201380009507.7A
Other languages
English (en)
Chinese (zh)
Other versions
CN104254338A (zh
Inventor
朱安-卡洛斯·洛布里加特-奥古斯提
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratec SL
Original Assignee
Laboratec SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratec SL filed Critical Laboratec SL
Publication of CN104254338A publication Critical patent/CN104254338A/zh
Application granted granted Critical
Publication of CN104254338B publication Critical patent/CN104254338B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3486—Humulus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN201380009507.7A 2012-02-15 2013-01-22 用于治疗尿失禁和遗尿症的药物组合物 Expired - Fee Related CN104254338B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES201230242A ES2423254B1 (es) 2012-02-15 2012-02-15 Composición farmacéutica para el tratamiento de incontinencia urinaria y enuresis
ESP201230242 2012-02-15
PCT/ES2013/070022 WO2013121061A1 (es) 2012-02-15 2013-01-22 Composición farmacéutica para el tratamiento de incontinencia urinaria y enuresis

Publications (2)

Publication Number Publication Date
CN104254338A CN104254338A (zh) 2014-12-31
CN104254338B true CN104254338B (zh) 2019-05-31

Family

ID=48983578

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380009507.7A Expired - Fee Related CN104254338B (zh) 2012-02-15 2013-01-22 用于治疗尿失禁和遗尿症的药物组合物

Country Status (20)

Country Link
US (1) US9272011B2 (cg-RX-API-DMAC7.html)
EP (1) EP2815755A4 (cg-RX-API-DMAC7.html)
JP (1) JP6203761B2 (cg-RX-API-DMAC7.html)
KR (1) KR20140127874A (cg-RX-API-DMAC7.html)
CN (1) CN104254338B (cg-RX-API-DMAC7.html)
AU (1) AU2013220284A1 (cg-RX-API-DMAC7.html)
BR (1) BR112014020154A8 (cg-RX-API-DMAC7.html)
CA (1) CA2864426A1 (cg-RX-API-DMAC7.html)
CL (1) CL2014002128A1 (cg-RX-API-DMAC7.html)
CO (1) CO7141408A2 (cg-RX-API-DMAC7.html)
CR (1) CR20140419A (cg-RX-API-DMAC7.html)
EA (1) EA028184B1 (cg-RX-API-DMAC7.html)
ES (1) ES2423254B1 (cg-RX-API-DMAC7.html)
IL (1) IL233978A0 (cg-RX-API-DMAC7.html)
MA (1) MA37324A1 (cg-RX-API-DMAC7.html)
MX (1) MX367671B (cg-RX-API-DMAC7.html)
PE (1) PE20142324A1 (cg-RX-API-DMAC7.html)
PH (1) PH12014501823A1 (cg-RX-API-DMAC7.html)
WO (1) WO2013121061A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201406668B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110339316B (zh) * 2019-08-09 2021-09-21 河南中医药大学 一种治疗中风后尿失禁的中药
CN116036153B (zh) * 2023-02-22 2023-09-26 深圳市儿童医院 啤酒花提取物在制备用于治疗或者预防抑郁症、抑郁症并发症、焦虑症的产品中的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061135A1 (en) * 1999-04-08 2000-10-19 Warner-Lambert Company Method for the treatment of incontinence
JP2003088335A (ja) * 2001-09-14 2003-03-25 Pharmafoods Kenkyusho:Kk 排尿機能改善用食品組成物及びそれを含有する飲食品
CN1867327A (zh) * 2003-09-11 2006-11-22 什诺波特有限公司 使用gaba类似物的前药治疗和/或预防尿失禁
EP1889612A2 (en) * 2006-07-24 2008-02-20 Jan Kees Piet Bruinstroop Method for controlling micturition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009560A1 (en) 1990-11-27 1992-06-11 Northwestern University Gaba and l-glutamic acid analogs for antiseizure treatment
WO1993023383A1 (en) 1992-05-20 1993-11-25 Northwestern University Gaba and l-glutamic acid analogs for antiseizure treatment
FR2823672B1 (fr) * 2001-04-23 2004-03-12 Berkem Sa Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes
GB0306568D0 (en) * 2003-03-21 2003-04-30 Unilever Plc Compositions of natural products and use thereof
NZ526350A (en) * 2003-06-09 2004-10-29 A Anti-aging compositions comprising an amino acid, vitamin B complex, metal salt and an amino alcohol
CN101242850B (zh) * 2003-10-09 2013-03-20 太平洋艾瑞有限公司 文冠果的提取物和从提取物分离出的化合物的组成，功能和应用，以及它们的制备方法
US20070116839A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-Potency Sweetener Composition With C-Reactive Protein Reducing Substance and Compositions Sweetened Therewith
US20090180999A1 (en) * 2008-01-11 2009-07-16 U.S. Nutraceuticals, Llc D/B/A Valensa International Method of preventing, controlling and ameliorating urinary tract infections using cranberry derivative and d-mannose composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061135A1 (en) * 1999-04-08 2000-10-19 Warner-Lambert Company Method for the treatment of incontinence
JP2003088335A (ja) * 2001-09-14 2003-03-25 Pharmafoods Kenkyusho:Kk 排尿機能改善用食品組成物及びそれを含有する飲食品
CN1867327A (zh) * 2003-09-11 2006-11-22 什诺波特有限公司 使用gaba类似物的前药治疗和/或预防尿失禁
EP1889612A2 (en) * 2006-07-24 2008-02-20 Jan Kees Piet Bruinstroop Method for controlling micturition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
啤酒花的化学成分、药理作用与临床应用;应雀森;《国外医药 植物药分册》;20080715;第23卷(第4期);第139页左栏第1、3段，第141页右栏倒数第2段 *
酒花的化学成分及药理作用;朱丹;《中国药业》;20081105;第17卷(第21期);第1-3页 *

Also Published As

Publication number Publication date
CR20140419A (es) 2014-11-28
PH12014501823A1 (en) 2014-11-24
CO7141408A2 (es) 2014-12-12
US9272011B2 (en) 2016-03-01
IL233978A0 (en) 2014-09-30
PE20142324A1 (es) 2015-01-16
EA028184B1 (ru) 2017-10-31
ES2423254A1 (es) 2013-09-18
CN104254338A (zh) 2014-12-31
CL2014002128A1 (es) 2015-03-13
EP2815755A4 (en) 2015-08-05
MX2014009464A (es) 2014-11-12
BR112014020154A8 (pt) 2017-07-11
ZA201406668B (en) 2016-05-25
US20150044308A1 (en) 2015-02-12
AU2013220284A1 (en) 2014-09-25
MA37324A1 (fr) 2016-03-31
MX367671B (es) 2019-08-30
EA201491437A1 (ru) 2015-06-30
BR112014020154A2 (cg-RX-API-DMAC7.html) 2017-06-20
JP2015507002A (ja) 2015-03-05
CA2864426A1 (en) 2013-08-22
WO2013121061A1 (es) 2013-08-22
EP2815755A1 (en) 2014-12-24
KR20140127874A (ko) 2014-11-04
ES2423254B1 (es) 2014-03-26
JP6203761B2 (ja) 2017-09-27

Similar Documents

Publication Publication Date Title
Ellingwood American materia medica, therapeutics and pharmacognosy: developing the latest acquired knowledge of drugs, and especially of the direct action of single drugs upon exact conditions of disease, with especial reference to the therapeutics of the plant drugs of the Americas
RU2174003C1 (ru) Фармацевтическая лечебная композиция, способ лечебного и лечебно-профилактического ее применения
CN111743934A (zh) 一种肠道菌群调节中药组合物及其应用
RU2419449C1 (ru) Средство для лечения больных лекарственным гепатитом
CN104254338B (zh) 用于治疗尿失禁和遗尿症的药物组合物
RU2431494C1 (ru) Антипаразитарный сбор
US11179430B2 (en) Extracts from mother-of-thyme and the use i'hereof
Stella et al. Datura stramonium intake: a report on three cases
CN102793870B (zh) 一种治疗肾结石的中草药
RU2411955C1 (ru) Средство для лечения дисбиоза кишечника у больных с хроническим криптогенным гепатитом
Murti et al. Exploring the therapeutic potential of Moringa oleifera Lam. in Traditional Chinese Medicine: A comprehensive review
CN101049386B (zh) 一种治疗痔疮的药酒
CN110917249A (zh) 一种用于前列腺的中药组合物及其制备方法和应用
RU2556962C1 (ru) Способ лечения хронического описторхоза у больных с розацеа
CN102846870A (zh) 苗族外用消炎药及制备工艺
CN108079049A (zh) 党参黄芪组合物用于制备治疗抑郁症的药物的用途
CN109260255A (zh) 一种木本复方防暑精油及其制备方法
DE202018105573U1 (de) Pharmazeutische Zusammensetzung zur Behandlung der Harninkontinenz und Enuresis
CN103285188B (zh) 一种益气补肾活血的中药组合物及其制备方法
Sharma Clinical study on effect of swarnamritaprashana (modified Swarna Prashana) in the management of Shayyamutra in Children
CN113842417A (zh) 一种舒缓助眠草本配方及制作方法
Copland A Memoir on the Employment of Terebinthinous Remedies in Disease
EP2394654A1 (en) Herbal composition having cox-2 and immune activities and preparation method thereof
sREYNOLD PROGRESS OF MEDICAL SCIENCE.
Andrews The Medical Summary: A Monthly Journal of Practical Medicine, New Preparations

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20190531

CF01 Termination of patent right due to non-payment of annual fee